Senior Manager, Global CMC Regulatory Affairs
Xeris Pharmaceuticals, Inc.
Summary
The Senior Manager of CMC Regulatory Affairs will be responsible for creating CMC regulatory development plans and for successful execution against those plans. The Senior Manager of CMC Regulatory Affairs represents the function on departmental and cross-functional initiatives. The Senior Manager must be articulate and influence decision-making with key internal and external stakeholders while managing tight timelines.
Job description
Essential Job Functions
- Serve as Global Chemistry, Manufacturing and Controls (CMC) regulatory leader for assigned products
- Prepare Global CMC content for INDs, NDAs, MAAs, IMPDs, CTAs, annual reports, and other regulatory documents
- Develop and create CMC regulatory strategy for integrated development plans and long-term planning at a cross-functional level for product(s), consistent with the corporate and project objectives
- Provide CMC regulatory expertise to Technical Operations and Quality teams
- Review and approve technical documentation
- Provide guidance to teams in support of clinical trial supply for local and global clinical trials
- Engage with regulatory agencies on CMC project related matters as requested
- Identify regulatory CMC issues proactively that will impact programs and provide strategies to address them and communicate to the project team
- Provide insight and guidance on implementation of regulations with respect to the preparation and submission of CMC regulatory documentation
- Drive decision making in the cross functional teams with respect to CMC regulatory issues
- Create CMC regulatory submission timelines in collaboration with cross functional teams
- Manage internal team and external consultants/vendors to CMC regulatory timelines
Skills and Qualifications
- B.S. in a scientific discipline required, B.S. in chemistry, pharmaceutical sciences or similar discipline preferred.
- Diverse technology experience (small molecules, biologics, parenteral and oral dosage forms)
- Must have a minimum of 5 years of pharmaceutical industry experience to include 5 years dedicated to CMC regulatory affairs matters; international experience preferred
- In depth knowledge of drug development, US and global CMC guidelines and regulations.
Competencies
Functional Leadership skills, Negotiation skills, Teamwork & Collaboration, Attention to Detail, Self-Starter, Problem Solving, Organizational skills, Adaptability, Professionalism, Written and Verbal Communications, Analytical skills.
Working Conditions
This is a hybrid position based in Xeris’ Chicago office and a minimum of three days per week on-site is required. On-site requirement may change at management’s discretion. Position may require periodic evening and weekend work, as necessary to fulfill obligations. Periodic overnight travel. Travel up to 10% may be required to accomplish corporate goals and health authority requirements.
Requirements
- B.S. in a scientific discipline required
- B.S. in chemistry, pharmaceutical sciences or similar discipline preferred
- Diverse technology experience (small molecules, biologics, parenteral and oral dosage forms)
- Minimum of 5 years of pharmaceutical industry experience
- 5 years dedicated to CMC regulatory affairs matters
- International experience preferred
- In depth knowledge of drug development, US and global CMC guidelines and regulations
- Functional Leadership skills
- Negotiation skills
- Teamwork & Collaboration
- Attention to Detail
- Self-Starter
- Problem Solving
- Organizational skills
- Adaptability
- Professionalism
- Written and Verbal Communications
- Analytical skills
Benefits
- Paid time off
- Health insurance
- Vision insurance
- Dental insurance
- 401(k) retirement benefits
- Equity awards
- Long-term incentive awards
- Annual bonus
Company overview
Xeris Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing ready-to-use injectable and infusible drug formulations. The company leverages its proprietary XeriJect® and XeriSol® technology platforms to transform existing liquid and lyophilized medications into stable, non-aqueous, ready-to-use formulations that eliminate the need for reconstitution or refrigeration. Xeris specializes in addressing unmet medical needs in endocrinology, neurology, and gastroenterology, with a particular emphasis on rescue therapies for severe hypoglycemia and other acute conditions. The company's lead product, Gvoke® (glucagon injection), is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. Xeris operates as a publicly traded company on the NASDAQ under the ticker symbol XERS, with a focus on improving patient outcomes through innovative drug delivery solutions that enhance convenience, safety, and accessibility of critical medications.